Instalab
logoInstalab

Lactobacillus Iners

Vaginal Swab Test
See whether your vaginal microbiome is in a stable protective state or a fragile one prone to infections and pregnancy complications.
4.9 (4,560 reviews)
Tested by US Biotek Laboratories
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Lactobacillus Iners test?

This test is most useful if any of these apply to you.

Planning or Going Through Pregnancy
Early-pregnancy L. iners dominance has been linked to higher preterm birth risk in some studies; testing helps clarify your microbiome state.
Dealing With Recurrent BV or Yeast
Recurrent infections often trace back to an L. iners-dominated community that recovers from antibiotics but stays fragile and prone to relapse.
Trying to Conceive or Doing IVF
Cervical microbiomes higher in L. crispatus and lower in L. iners have been linked to more favorable pregnancy outcomes in assisted reproduction.
Healthy but Want a Real Read on Your Microbiome
Standard exams cannot tell which Lactobacillus dominates your vagina; this test reveals the species-level pattern that shapes future risk.

About Lactobacillus Iners

Two women can both have a vagina full of Lactobacillus and still face very different risks. The species matters. If your dominant Lactobacillus is L. iners (Lactobacillus iners) rather than L. crispatus, your microbiome is more likely to drift into bacterial vaginosis, harbor Candida, allow chlamydia to take hold, or shift in ways that can raise the risk of preterm birth in some populations.

A vaginal swab test that quantifies L. iners tells you which kind of Lactobacillus-dominated state you are in. That single distinction reframes the picture for women trying to conceive, planning a pregnancy, dealing with recurrent infections, or simply trying to understand a reproductive health story that standard panels miss.

What L. iners Actually Signals

L. iners is one of the most common bacteria in the reproductive-age vagina, detected in a majority of samples in molecular panels. It produces lactic acid but, unlike L. crispatus, it makes only limited amounts of hydrogen peroxide and lacks D-lactic acid production. That biochemistry translates into weaker pathogen inhibition and a less stable community. Researchers describe L. iners as a transitional species that thrives in disturbed ecosystems and can flip more easily between healthy and dysbiotic states.

A high L. iners signal generally means your vaginal environment is dominated by a Lactobacillus that offers less protection than L. crispatus and is more prone to instability. A low L. iners signal alongside high L. crispatus or high total Lactobacillus usually indicates a more robust ecosystem. L. iners that is high within a broadly disturbed community is a marker of transition or recovery rather than protection.

Bacterial Vaginosis and Vaginal Dysbiosis

L. iners often sits at both ends of a bacterial vaginosis (BV) episode. It commonly dominates before BV develops, persists during dysbiosis when other Lactobacilli have been wiped out, and is frequently the species that repopulates the vagina after metronidazole. A meta-analysis comparing L. iners-dominated and L. crispatus-dominated states reported a roughly 2.1-fold higher prevalence of BV in the L. iners group, though the confidence interval crossed 1.0, so this trend was not statistically significant.

There is a counterintuitive twist worth understanding. In one study of 541 women, higher pre-treatment L. iners was associated with better BV cure rates after metronidazole, and some L. iners strains directly inhibited Gardnerella vaginalis in laboratory tests. This is not a contradiction. L. iners is not a simple good-versus-bad number. It is a phenotype indicator. A community where L. iners is the last remaining Lactobacillus may help maintain enough acid environment to support antibiotic recovery, even while that same community is more vulnerable to dysbiosis returning.

Sexually Transmitted Infections

Vaginal microbiota dominated by L. iners has been linked to higher susceptibility to Chlamydia trachomatis. A 2023 meta-analysis pooling six studies found that L. iners-dominated communities were associated with about 3.4 times higher odds of chlamydia infection compared with L. crispatus-dominated ones. The Dutch case-control study of 122 women that contributed to this pooled estimate found a smaller individual effect (odds ratio about 2.6), illustrating how the relationship looks across different populations.

Research in younger South African women has also shown that less stable, non-L. crispatus communities, including L. iners-rich states, correlate with greater HIV susceptibility at a community level. L. iners on its own does not cause infection, but it identifies an ecosystem where pathogens face less resistance.

Pregnancy and Preterm Birth

L. iners is among the most studied vaginal bacteria in pregnancy. Early dominance has been linked to higher rates of recurrent spontaneous preterm birth in a prospective cohort of 152 women, and a separate study of 111 healthy pregnant women found that L. iners alone as the dominant Lactobacillus in early pregnancy was associated with later preterm delivery. The picture is not uniform across all populations, however. A 2024 systematic review and meta-analysis found that L. iners dominance was actually associated with lower preterm birth risk in some pooled analyses, so the relationship appears to be population- and context-dependent.

Across studies, L. iners-dominant pregnancies are more likely to transition to non-Lactobacillus states as gestation progresses, which is the broader pattern linked to preterm birth risk. A study in Chinese healthy pregnant women found that L. iners may help maintain ecosystem stability in some populations, so the species-by-context interaction is real.

Candida and Group B Streptococcus Colonization

In a study of 255 reproductive-age women, L. iners-dominant microbiomes were about three times more likely to harbor Candida than L. crispatus-dominant ones. A separate study of 93 pregnant women showed that persistent group B Streptococcus (GBS) colonization throughout pregnancy was tied to higher L. iners and lower L. crispatus abundance. A culture-based study of 1,860 women in the third trimester showed that L. crispatus, but not L. iners, was inversely associated with GBS.

Fertility, IVF, and Cervical Cancer Outcomes

In a study of 88 women undergoing assisted reproductive technology, cervical microbiomes higher in L. crispatus and lower in L. iners were associated with more favorable pregnancy outcomes. In a separate study of 125 cervical cancer patients receiving chemoradiotherapy, L. iners abundance before treatment was identified as a potential biomarker of recurrence.

Why a Single Reading Is Not Enough

The vaginal microbiome is dynamic. Composition shifts across the menstrual cycle, with sexual activity, contraception, pregnancy, postpartum recovery, antibiotics, and probiotics. A single L. iners reading captures a moment, not a trajectory. What matters most is the pattern. Is L. iners stable as the dominant species, or is it the species that takes over when others fall away?

Get a baseline, then retest at 3 to 6 months if you are changing anything that affects the vaginal environment, such as starting probiotics, completing BV treatment, planning pregnancy, or switching contraception. After that, annual testing is reasonable. If you are actively trying to conceive, are pregnant, or recovering from recurrent infections, more frequent monitoring helps you see whether your community is drifting toward an L. crispatus-rich state or settling into a less protective L. iners-dominated one.

When Results Can Be Misleading

Several common factors can distort a single L. iners reading. Knowing what they are helps you avoid misinterpreting your result.

  • Recent vaginal sex: a study of 80 women in sub-Saharan Africa found that swabs taken within 24 to 48 hours of vaginal sex showed reduced L. iners concentrations and increased inflammatory signals. Wait at least two days after sex before sampling.
  • Recent antibiotics: azithromycin given for chlamydia frequently produces L. iners-dominated communities that can persist up to 9 months. Metronidazole for BV often leaves L. iners as the recovering species. Wait several weeks after antibiotic completion to capture a representative reading.
  • Childbirth and early postpartum: a longitudinal study showed that childbirth causes an abrupt loss of Lactobacillus dominance, with only about 49 percent of women regaining a Lactobacillus-dominant community within a year. Results in the postpartum period reflect this transition, not a stable baseline.
  • Menstrual phase and contraception: hormonal status influences which Lactobacillus species dominate. Evidence on progestin-injectable contraception is mixed, with some studies linking it to lower L. iners or more diverse communities and others finding little change, so interpret results in context.

What to Do With an Unexpected Result

If your swab shows high L. iners and low L. crispatus, the most useful next step is to look at the broader picture rather than chase the single number. Pair this result with a full vaginal microbiome panel that quantifies L. crispatus, L. gasseri, L. jensenii, Gardnerella vaginalis, Atopobium vaginae, Candida species, and pH. Together these tell you whether your community is L. iners-dominant in a Lactobacillus-rich way, sitting in a transitional state, or trending toward overt dysbiosis.

If you have symptoms, recurrent BV, recurrent yeast, fertility concerns, or a history of preterm birth, share these results with a gynecologist who works with microbiome-informed care. If you are planning pregnancy, addressing an L. iners-dominant state before conception is a reasonable goal, though specific interventions to reliably shift L. iners are still being studied and no FDA-approved therapy specifically targets L. iners replacement. If you are pregnant and the result shows early L. iners dominance, a maternal-fetal medicine specialist can help integrate this signal with cervical length and other risk markers.

How to Read Your Number in Context

Because L. iners is a research-grade marker without standardized clinical cutpoints, the most useful approach is comparative rather than absolute. Look at the ratio of L. crispatus to L. iners in your result. A community heavy in L. crispatus with low L. iners is generally favorable. A community heavy in L. iners with little L. crispatus is the pattern most consistently linked to higher risks in many studies. A community where neither dominates and BV-associated bacteria are creeping in is the pattern most likely to need attention.

What Moves This Biomarker

Evidence-backed interventions that affect your Lactobacillus Iners level

Increase
Take azithromycin (single 1 gram dose) for chlamydia
If you take azithromycin for chlamydia, your vaginal community often shifts toward an L. iners-dominated state and stays there. In a study of 149 women, this nonoptimal pattern persisted for up to 9 months after treatment, meaning a single course of antibiotics can leave you in a less protective microbiome for nearly a year.
MedicationStrong Evidence
Decrease
Childbirth (vaginal or cesarean)
Childbirth causes an abrupt loss of Lactobacillus dominance, including L. iners, and a sharp rise in inflammatory signals. Only about 49 percent of women regain a Lactobacillus-dominant community within one year postpartum. Postpartum microbiome readings reflect this transition, not your long-term baseline, so wait until at least a year after delivery for a stable result if possible.
LifestyleStrong Evidence
Increase
Take metronidazole for bacterial vaginosis
Metronidazole clears BV-associated bacteria but often leaves L. iners as the species that repopulates the vagina. In a study of 541 women, higher pretreatment L. iners predicted better BV cure rates and some strains inhibited Gardnerella in laboratory tests. The post-treatment increase reflects ecological recovery, but the resulting L. iners-dominant state is less stable than a L. crispatus-dominant one.
MedicationModerate Evidence
Decrease
Use a vaginal L. crispatus probiotic (LACTIN-V CTV-05) after BV treatment
If you use a vaginal L. crispatus probiotic after standard BV antibiotic treatment, you shift the recovering community toward L. crispatus dominance rather than L. iners dominance. The main LACTIN-V randomized placebo-controlled efficacy trial in 228 women showed reduced BV recurrence, and an immunological substudy of 66 women from that trial showed sustained reductions in genital inflammation and improved epithelial integrity, both of which matter for BV recurrence, HIV susceptibility, and reproductive outcomes.
SupplementModerate Evidence
Decrease
Use a vaginal Lactobacillus suppository (VagiBIOM) in perimenopause
If you use a vaginal multi-strain Lactobacillus suppository in perimenopause, vaginal Lactobacillus diversity increases and symptoms like itching decrease. In a randomized trial of 66 perimenopausal women with BV, suppository use significantly improved a composite vaginal health index over the treatment period. Shifting toward a more diverse, L. crispatus-rich community generally lowers relative L. iners dominance.
SupplementModerate Evidence
Decrease
Recent vaginal sex within 24 to 48 hours of sampling
If you have vaginal sex within 24 to 48 hours of a swab, L. iners concentrations can drop transiently and inflammatory signals rise. In a study of 80 sub-Saharan African women, swabs positive for prostate-specific antigen (a marker of recent semen exposure) showed lower L. iners and more inflammation. The shift is short-term, with most microbiome disruptions from condomless sex resolving within 2 to 3 days, and can make a single swab unrepresentative of your usual community.
LifestyleModerate Evidence
Decrease
Progestin-injectable hormonal contraception
Evidence on progestin-injectable contraception and the vaginal microbiome is mixed. Some studies in sub-Saharan African women have linked it to lower L. iners, greater overall diversity, and more inflammation, while other studies have found little broad change in microbiome composition or inflammatory markers. If you are on injectable progestin and your swab shows depleted L. iners with rising diversity, the contraception may be contributing, but interpret the result in clinical context.
MedicationModest Evidence

Frequently Asked Questions

Panels containing Lactobacillus Iners

Lactobacillus Iners is included in these pre-built panels.

References

26 studies
  1. Walther-antonio M, Jeraldo P, Berg Miller ME, Yeoman C, Nelson K, Wilson B, White B, Chia N, Creedon DPLoS ONE2014
  2. Mehta O, Ghosh T, Kothidar a, Gowtham M, Mitra R, Kshetrapal PMicrobial Ecology2020
  3. Wang X, Jiang Q, Tian X, Chen W, Mai J, Lin GNPJ Biofilms and Microbiomes2025
  4. Zheng N, Guo R, Wang J, Zhou W, Ling ZFrontiers in Cellular and Infection Microbiology2021
  5. Muzny C, Blanchard E, Taylor C, Aaron K, Talluri R, Griswold MJournal of Infectious Diseases2018